García-López P - Search Results

1

Leishmania mexicana promastigotes secrete a protein tyrosine phosphatase.

Escalona-Montaño AR, Pardavé-Alejandre D, Cervantes-Sarabia R, García-López P, Gutiérrez-Quiroz M, Gutiérrez-Kobeh L, Becker-Fauser I, Aguirre-García MM. Escalona-Montaño AR, et al. Parasitol Res. 2010 Jul;107(2):309-15. doi: 10.1007/s00436-010-1863-5. Epub 2010 Apr 20. Parasitol Res. 2010. PMID: 20405143

2

The systemic absorption of etoposide after intravaginal administration in patients with cervical intraepithelial lesions associated with human papillomavirus infection.

García-López P, Coll M, Cervera E, Reyes-Vermot L, Torres MA, Abrego-Pérez G, Hernández-Pájaro AI, Castañeda-Hernandez G, Mohar-Betancourt A, Meneses A. García-López P, et al. Pharm Res. 2006 Feb;23(2):378-83. doi: 10.1007/s11095-005-9142-3. Epub 2006 Jan 1. Pharm Res. 2006. PMID: 16388409 Clinical Trial.

3

Renoprotection by alpha-Mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity.

Pérez-Rojas JM, Cruz C, García-López P, Sánchez-González DJ, Martínez-Martínez CM, Ceballos G, Espinosa M, Meléndez-Zajgla J, Pedraza-Chaverri J. Pérez-Rojas JM, et al. Free Radic Res. 2009;43(11):1122-32. doi: 10.1080/10715760903214447. Free Radic Res. 2009. PMID: 19863372

4

Comparison between Sprague-Dawley and Wistar rats as an experimental model of pharmacokinetic alterations induced by spinal cord injury.

García-López P, Pérez-Urizar J, Ibarra A, Grijalva I, Madrazo I, Flores-Murrieta F, Castañeda-Hernández G, Guízar-Sahagún G. García-López P, et al. Arch Med Res. 1996 Winter;27(4):453-7. Arch Med Res. 1996. PMID: 8987177

5

Acute spinal cord injury changes the disposition of some, but not all drugs given intravenously.

García-López P, Martínez-Cruz A, Guízar-Sahagún G, Castañeda-Hernández G. García-López P, et al. Spinal Cord. 2007 Sep;45(9):603-8. doi: 10.1038/sj.sc.3102001. Epub 2006 Dec 19. Spinal Cord. 2007. PMID: 17179977

6

Oral paracetamol bioavailability in rats subjected to experimental spinal cord injury.

García-López P, Pérez-Urizar J, Madrazo I, Guízar-Sahagún G, Castañeda-Hernández G. García-López P, et al. Biopharm Drug Dispos. 1997 Apr;18(3):203-11. doi: 10.1002/(sici)1099-081x(199704)18:3<203::aid-bdd11>3.0.co;2-f. Biopharm Drug Dispos. 1997. PMID: 9113343

7

Understanding drug disposition alterations induced by acute spinal cord injury: role of injury level and route of administration for agents submitted to extensive liver metabolism.

Cruz-Antonio L, Flores-Murrieta FJ, García-Löpez P, Guízar-Sahagún G, Castañeda-Hernández G. Cruz-Antonio L, et al. J Neurotrauma. 2006 Jan;23(1):75-85. doi: 10.1089/neu.2006.23.75. J Neurotrauma. 2006. PMID: 16430374

8

Alteration of phenacetin pharmacokinetics after experimental spinal cord injury.

Cruz L, Castañeda-Hernández G, Flores-Murrieta FJ, García-López P, Guízar-Sahagún G. Cruz L, et al. Proc West Pharmacol Soc. 2002;45:4-5. Proc West Pharmacol Soc. 2002. PMID: 12434508 No abstract available.

9

Pathophysiological mechanisms involved in systemic and metabolic alterations secondary to spinal cord injury.

Guízar-Sahagún G, Castañeda-Hernández G, García-López P, Franco-Bourland R, Grijalva I, Madrazo I. Guízar-Sahagún G, et al. Proc West Pharmacol Soc. 1998;41:237-40. Proc West Pharmacol Soc. 1998. PMID: 9836299 Review. No abstract available.

10

Bioavailability of diclofenac after intramuscular administration to rats with experimental spinal cord injury.

García-López P, Salas R. García-López P, et al. J Pharmacol Toxicol Methods. 1999 Oct;42(2):99-101. doi: 10.1016/s1056-8719(00)00049-6. J Pharmacol Toxicol Methods. 1999. PMID: 10924893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters